Propel Bio Management, LLC
- SEC CIK
- 0001969764
- Latest filing
- Aug 13, 2026
Holdings in Q4 2024
Holdings as of Dec 31, 2024, filed Feb 14, 2025. Long positions only; changes compare share counts with Q3 2024.
- Positions
- 21
- 0 vs. Q3 2024
- Portfolio value
- $100.7M
- −$71.7M (−41.6%) vs. Q3 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PAGPPlains GP Holdings LP | LTD PARTNR INT A | 1,272,360 | $23.4M | 23.2% | 00.0% | Unchanged | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 43,032 | $13.3M | 13.2% | 00.0% | Unchanged | History |
| AKROAkero Therapeutics, Inc. | COM | 343,729 | $9.56M | 9.5% | 00.0% | Unchanged | History |
| ACHVAchieve Life Sciences, Inc. | COM | 2,453,092 | $8.63M | 8.6% | 00.0% | Unchanged | History |
| APLTApplied Therapeutics, Inc. | COM | 9,615,420 | $8.23M | 8.2% | +3,047,562+46.4% | Added | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 989,927 | $8.04M | 8.0% | +120,000+13.8% | Added | History |
| TCRXTScan Therapeutics, Inc. | COM | 2,087,139 | $6.34M | 6.3% | 00.0% | Unchanged | History |
| Avidity Biosciences, Inc.05370A108 | COM | 178,500 | $5.19M | 5.2% | 00.0% | Unchanged | – |
| ARDXArdelyx, Inc. | COM | 950,947 | $4.82M | 4.8% | −120,000−11.2% | Reduced | History |
| ABEOAbeona Therapeutics Inc. | COM NEW | 624,022 | $3.48M | 3.5% | 00.0% | Unchanged | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 183,259 | $2.42M | 2.4% | +50,000+37.5% | Added | History |
| KYMRKymera Therapeutics, Inc. | COM | 56,359 | $2.27M | 2.3% | 00.0% | Unchanged | History |
| ZVRAZevra Therapeutics, Inc. | COM NEW | 179,874 | $1.50M | 1.5% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 130,000 | $1.13M | 1.1% | 00.0% | Unchanged | History |
| LONALeonaBio, Inc. | COM | 1,492,792 | $875.8K | 0.9% | 00.0% | Unchanged | History |
| EIGREiger BioPharmaceuticals, Inc. | COM NEW | 146,381 | $765.0K | 0.8% | 00.0% | Unchanged | History |
| JSPRJasper Therapeutics, Inc. | COM NEW | 20,000 | $427.6K | 0.4% | +20,000 | New | History |
| DCTHDelcath Systems, Inc. | COM NEW | 17,000 | $204.7K | 0.2% | +17,000 | New | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 25,209 | $95.3K | 0.1% | −54,791−68.5% | Reduced | History |
| Maat Pharma SacaF5888J116 | COMM | 3,151 | $25.1K | <0.1% | +754+31.5% | Added | – |
| Contra Chinook Therapeu169CVR016 | COM | 79,357 | $9.75K | <0.1% | 00.0% | Unchanged | – |
Sold out since Q3 2024 (2)
Positions held at the end of Q3 2024 that are gone from this filing.